Cargando…
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression
Increased number of tumor-infiltrating CD8+ lymphocytes is associated with improved survival in patients with advanced stage high grade serous ovarian cancer (HGSOC) but the underlying molecular mechanism has not been thoroughly explored. Using transcriptome profiling of microdissected HGSOC tissue...
Autores principales: | Yeung, Tsz-Lun, Tsai, Ching Chou, Leung, Cecilia S., Au Yeung, Chi-Lam, Thompson, Melissa S., Lu, Karen H., Freedman, Ralph S., Birrer, Michael J., Wong, Kwong-Kwok, Mok, Samuel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316352/ https://www.ncbi.nlm.nih.gov/pubmed/30469497 http://dx.doi.org/10.3390/cancers10120464 |
Ejemplares similares
-
ISG15 and ISGylation in Human Diseases
por: Mirzalieva, Oygul, et al.
Publicado: (2022) -
The Functional Roles of ISG15/ISGylation in Cancer
por: Yuan, Yin, et al.
Publicado: (2023) -
Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators
por: Kim, Ye Ji, et al.
Publicado: (2016) -
HyperISGylation of Old World Monkey ISG15 in Human Cells
por: Pattyn, Els, et al.
Publicado: (2008) -
ISG15 suppresses ovulation and female fertility by ISGylating ADAMTS1
por: Chen, Yaru, et al.
Publicado: (2023)